Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Prepaid Assets (2023 - 2025)

Kura Oncology (KURA) has disclosed Prepaid Assets for 3 consecutive years, with $32.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 109.48% to $32.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $32.2 million, a 109.48% increase, with the full-year FY2025 number at $32.2 million, up 109.48% from a year prior.
  • Prepaid Assets was $32.2 million for Q4 2025 at Kura Oncology, down from $35.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $35.1 million in Q3 2025 to a low of $7.3 million in Q3 2023.
  • A 3-year average of $15.5 million and a median of $10.6 million in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: dropped 4.82% in 2024, then soared 344.27% in 2025.
  • Kura Oncology's Prepaid Assets stood at $8.5 million in 2023, then surged by 80.36% to $15.4 million in 2024, then surged by 109.48% to $32.2 million in 2025.
  • Per Business Quant, the three most recent readings for KURA's Prepaid Assets are $32.2 million (Q4 2025), $35.1 million (Q3 2025), and $24.8 million (Q2 2025).